Evidence map›Paper›PMID 31139486›Full record

ArticleCase reports in psychiatry2019

Use of ECT in Major Vascular Neurocognitive Disorder with Treatment-Resistant Behavioral Disturbance following an Acute Stroke in a Young Patient.

Kyle E Rodenbach, Daniel Varon, Timothey Denko, Ryan Peterson, Carmen Andreescu

Open access · goldAbstract readCase Reports
In one paragraph

Article in Case reports in psychiatry, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact, top 96% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed, 0 citations in OpenAlex.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 1 institution in 1 country.

Kyle E RodenbachUniversity of Pittsburgh Medical Center, Department of Psychiatry, 3811 O'Hara Street, Pittsburgh, PA 15213, USA.
Daniel VaronUniversity of Pittsburgh Medical Center, Department of Psychiatry, 3811 O'Hara Street, Pittsburgh, PA 15213, USA.ORCID 0000-0003-0699-8679
Timothey DenkoUniversity of Pittsburgh Medical Center, Department of Psychiatry, 3811 O'Hara Street, Pittsburgh, PA 15213, USA.
Ryan PetersonUniversity of Pittsburgh Medical Center, Department of Psychiatry, 3811 O'Hara Street, Pittsburgh, PA 15213, USA.
Carmen AndreescuUniversity of Pittsburgh Medical Center, Department of Psychiatry, 3811 O'Hara Street, Pittsburgh, PA 15213, USA.ORCID 0000-0003-3767-5127
University of Pittsburgh Medical Center · US

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The following case describes the utilization of bitemporal ECT as a treatment of last resort in a 47-year-old woman with profoundly treatment-resistant behavioral disturbance poststroke. The use of ECT led to improvement in symptoms sufficient for discharge from an inpatient psychiatric unit to the nursing home. Neuropsychiatric sequelae of stroke include poststroke depression, anxiety, mania, psychosis, apathy, pathological laughter and crying, catastrophic reaction, and mild and major vascular neurocognitive disorders. Behavioral disturbance is common and may pose diagnostic and therapeutic difficulty in the poststroke patient. In most cases, first-line treatment includes pharmacologic intervention tailored to the most likely underlying syndrome. Frequent use of sedating medications is a more drastic option when behaviors prove recalcitrant to first-line approaches and markedly affect quality of life and patient safety. ECT is generally safe, is well tolerated, and may be effective in improving symptoms in treatment-resistant behavioral disturbance secondary to stroke with major neurocognitive impairment, as suggested in this case.

Identifiers

PMID31139486
PMCPMC6500662
OpenAlexW2936301372

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.